Solitary mastocytoma treated with tranilast

Journal of Dermatology

Volumn 23, Issue 5, 1996, Pages 335-339

  Katoh, Norito ^a   Hirano, Shinya ^a   Yasuno, Hirokazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

solitary mastocytoma; tranilast; treatment; urticaria pigmentosa

Indexed keywords

CORTICOSTEROID; TRANILAST;

ALLERGIC REACTION; ARTICLE; CASE REPORT; CHILD; FEMALE; HISTAMINE RELEASE; HUMAN; MALE; MAST CELL DEGRANULATION; MASTOCYTOMA; MEDIATOR RELEASE; ORAL DRUG ADMINISTRATION; PUVA; SKIN NODULE; TOPICAL DRUG ADMINISTRATION; URTICARIA PIGMENTOSA;

EID: 0029998363     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb04026.x     Document Type: Article

References (20)

1. Johnson CWC, Helwig EB: Solitary mastocytosis (urticaria pigmentosa), Arch Dermatol, 84: 148-157, 1961.
2. Bin AR, Nickerson M: Generalized flushing of the skin with urticaria pigmentosa, Arch Dermatol, 80: 311-317, 1959.
3. Lavker RM, Schechter NM: Cutaneous mast cell depletion results from topical coiticosteroid usage, J Immunol, 135: 2368-2375, 1985.
4. Guzzo C, Lavker RM, Roberts J, et al: Urticaria pigmentosa, systemic evaluation and successful treatment with topical steroids, Arch Dermatol, 127: 191-196, 1991.
5. Barton J, Lavker RM, Schechter NM, Lazarus GS: Treatment of urticaria pigmentosa with corticosteroids, Arch Dermatol, 121: 1516-1523, 1985.
6. Metcalfe DD: The treatment of mastocytosis: An overview, J Invest Dermatol, 96: 55s-59s, 1991.
7. Kettelhut BV, Berkebile C, Bradley D, Metcalfe DD: A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis, J Allergy Clin Immunol, 83: 866-870,1989.
8. Gerrard JW, Ko C: Urticaria pigmentosa: Treatment with cimetidine and chlorpheniramine, J Pediatrics, 94: 843-844, 1979.
9. Soter NA, Austen KF, Wasserman SI: Oral disodium cromoglycate in the treatment of systemic mastocytosis, N Engl J Med, 301: 465-469, 1979.
10. Czarnetzki BM: A double-blind cross-over study of the effect of ketotifen in uriticaria pigmentosa, Dermatologica, 166: 44-47, 1983.
11. Briffa DV, Eady RAJ, James MP, et al: Photochemotherapy (PUVA) in the treatment of uriticaria pigmentosa, Br J Dermatol, 109: 67-75, 1983.
12. Kolde G, Frosch PJ, Czarnetzki BM: Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations, J Invest Dermatol, 83: 175-178, 1984.
13. Azuma H, Banno K, Yashimura T: Pharmacological properties of N-(3′,4′-dimethoxycinnamoyl)anthranilic acid (N-5′), a new anti-atopic agent, Br J Pharmacol, 58: 483-488, 1976.
14. Ujiie A, Kojima M, Naito J, et al: Effect of N-5′ on histamine release from rat peritoneal exudate cells induced by calcium ionophore and ATP, Jpn J Pharmacol, 34: 9-14, 1984.
15. Komatsu H, Kojima M, Tatsumi N, et al: Study of the mechanism of inhibitory action of tranilast on chemical mediator release, Jpn J Pharmacol, 46: 43-51, 1988.
16. Soter NA: The skin in mastocytosis, J Invest Dermatol, 96:32S-39S, 1991.
17. Cochrane DE, Douglas WW: Calcium-induced extrusion of secretory granules (exocytosis) in mast cells exposed to 48/80 or the ionophores A-23187 and X-537A, Proc Natl Acad Sci USA, 71: 408-412, 1974.
18. Tasaka K, Mio M, Okamoto M: Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs, Ann Allergy, 56; 464-469, 1986.
19. Koda A, Kurashina Y, Nakazawa NM: The inhibition mechanism of histamine release by N-(3′,4′-dimethoxycin namoyl)anthranilic acid, Int Arch Allergy Appl Immunol, 77: 244-245, 1985.
20. Nishigaki T: Mast cell degranulation and its inhibition by an anti-allergic agent tranilast; An electron microscopic study, Virchows Arch [B], 55: 311-322, 1988.